Strong Q4 2024 Financial Performance and 2025 Outlook
February 6, 2025 - 17:33
In the fourth quarter of 2024, the company reported a remarkable 45% increase in revenue, reaching $13.53 billion. This surge was primarily fueled by significant volume growth from its flagship products, Mounjaro and Zepbound. The performance in this quarter showcases the company's robust market presence and the effectiveness of its growth strategies.
Additionally, non-incretin revenue experienced a solid 20% increase compared to the same period in 2023, reflecting the company's diverse portfolio and successful expansion into new therapeutic areas. The strong financial results indicate not only the popularity of its current offerings but also the potential for future growth.
Looking ahead, the company has provided guidance for 2025, emphasizing its commitment to innovation and market leadership. With a focus on enhancing product accessibility and exploring new opportunities, the company is well-positioned to sustain its momentum and deliver continued value to stakeholders in the coming year.
MORE NEWS
June 18, 2026 - 00:10
Chairman Kevin Warsh: Financial markets work less efficiently when they consider what Fed thinksFederal Reserve Chairman Kevin Warsh argued on Wednesday that financial markets become less efficient when traders and investors spend too much time guessing what the central bank will do next....
June 17, 2026 - 02:28
City Council rejects first reading of budget, amendment approved to finance Ajax Turner non-profitThe City Council held its second first reading of the Fiscal Year budget on Tuesday night, but the outcome mirrored the previous session. Despite cutting more than $697,000 in proposed spending,...
June 16, 2026 - 22:13
'El Jefe' speaks: forget about 2008, it's really more like 2004The most senior chief financial officer among New York-listed companies has a message for investors who are bracing for a repeat of the 2008 financial crisis: calm down. According to the executive,...
June 16, 2026 - 07:40
RBA interest rate decision live: Aussies 'forced into hibernation' brace for year of painThe Reserve Bank of Australia has announced its latest cash rate decision, keeping interest rates on hold at 4.35 percent. The move was widely expected by economists, but it offers little relief...